Atrial and ventricular flows across a transcatheter mitral valve by Hatoum, Hoda, Askegaard, Gunnar, Iyer, Ramji, Prasad Dasi, Lakshmi

Request full text

Transcatheter Mitral Valve Replacement: Functional Requirements for Device Design, Bench-Top, and Pre-Clinical Evaluation by Iyer, Ramji, Chalekian, Aaron, Lane, Randy, Evans, Mike, Yi, Seung, Morris, John

Get full text

Phenolic antibacterials from Piper betle in the prevention of halitosis by Ramji, Niranjan, Ramji, Nivedita, Iyer, Ritu, Chandrasekaran, S

Get full text

A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B by Yuen, Man‐Fung, Chen, Chi‐Yi, Liu, Chun‐Jen, Jeng, Wen‐Juei, Elkhashab, Magdy, Coffin, Carla S., Kim, Won, Greenbloom, Susan, Ramji, Alnoor, Lim, Young S., Kim, Yoon J., Fung, Scott K., Kim, Dong J., Jang, Jeong‐Won, Lee, Kwan Sik, Iyer, Radhakrishnan P., Macfarlane, Chelsea, Jackson, Kathy, Locarnini, Stephen A., Chan, Henry L. Y., Afdhal, Nezam H.

Get full text

Liver toxicity in the Phase 2 Catalyst 206 trial of Inarigivir 400 mg daily added to a nucleoside in HBV EAg negative patients by Agarwal, Kosh, Afdhal, Nezam, Coffin, Carla, Fung, Scott, Dusheiko, Geoffrey, Foster, Graham, Elkhashab, Magdy, Tam, Edward, Ramji, Alnoor, Iyer, Radhakrishnan, Kennedy, Patrick

Get full text

LBP04 - Liver toxicity in the Phase 2 Catalyst 206 trial of Inarigivir 400 mg daily added to a nucleoside in HBV EAg negative patients by Agarwal, Kosh, Afdhal, Nezam, Coffin, Carla, Fung, Scott, Dusheiko, Geoffrey, Foster, Graham, Elkhashab, Magdy, Tam, Edward, Ramji, Alnoor, Iyer, Radhakrishnan, Kennedy, Patrick

Get full text

GS-12-Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial by Yuen, Man-Fung, Chen, Chi-Yi, Liu, Chun-Jen, Jeng, RachelWen-Juei, Elkhashab, Magdy, Coffin, Carla, Kim, Won, Greenbloom, Susan, Ramji, Alnoor, Lim, Young-Suk, Kim, Yoon Jun, Fung, Scott, Kim, Dong Joon, Jang, JeongWon, Lee, Kwan Sik, Afdhal, Nezam, Iyer, Radhakrishnan, Macfarlane, Chelsea, Jackson, Kathy, Locarnini, Stephen, Chan, Henry

Get full text

FRI-327 - Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohort... by Yuen, M.-F., Elkashab, M., Chen, C.-Y., Coffin, C., Fung, S., Greenbloom, S., Jang, J.W., Jeng, R.W.-J., Kim, D.J., Kim, Y.J., Kim, W., Lee, K.S., Lim, Y.-S., Ramji, A., Iyer, R., Macfarlane, C., Jackson, K., Locarnini, S., Afdhal, N., Chan, H.

Get full text

Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the A... by Yuen, M.-F., Elkashab, M., Chen, C.-Y., Coffin, C., Fung, S., Greenbloom, S., Jang, J.W., Jeng, R.W.-J., Kim, D.J., Kim, Y.J., Kim, W., Lee, K.S., Lim, Y.-S., Ramji, A., Iyer, R., Macfarlane, C., Jackson, K., Locarnini, S., Afdhal, N., Chan, H.

Get full text

Relationship of maternal serum ferritin with foetal serum ferritin, birth weight and gestation by Bhargava, M, Iyer, P.U, Kumar, R, Ramji, S, Kapani, V, Bhargava, S.K

Get full text